Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Staar Surgical CoSTAA +1.25%83 EV-to-EBIT is 174.65 as of Jul. 22, 2026, which is 117% above its 10-year median of 80.45. GuruFocus rates STAA with a GF Score™ of 83/100 and a GF Value™ of $32.08 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 465 Medical Devices & Instruments companies, Staar Surgical Co ranks worse than 96.99% on this metric.
Staar Surgical Co (NAS:STAA) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Staar Surgical Co's Enterprise Value for the quarter that ended in Mar. 2026 was $804.3 Mil.
Staar Surgical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Staar Surgical Co EV-to-EBIT Related Terms
Staar Surgical Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Staar Surgical Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Staar Surgical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Staar Surgical Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Staar Surgical Co's EV-to-EBIT falls into.
Staar Surgical Co's current Enterprise Value is $1,081.8 Mil.
Staar Surgical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Staar Surgical Co (STAA) has a EV-to-EBIT of 174.65 as of Jul. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Staar Surgical Co and its competitors. This is 117% above median its historical median of 80.45. According to the industry distribution chart, Staar Surgical Co ranks #451 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 97%.
Is Staar Surgical Co's EV-to-EBIT too high?
Staar Surgical Co's current EV-to-EBIT of 174.65 is 117% above median its 10-year median of 80.45. The Medical Devices & Instruments industry median EV-to-EBIT is 18.43. Staar Surgical Co's value of 174.65 is 847.6% above this industry median. Based on the distribution chart, Staar Surgical Co ranks #451 out of 465 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Staar Surgical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's EV-to-EBIT compare to BLFS and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #451 out of 465 companies for EV-to-EBIT. This places Staar Surgical Co in the lower half of its industry. The industry median EV-to-EBIT is 18.43. Staar Surgical Co's value of 174.65 is 847.6% above this benchmark. While the company's 10-year median is 80.45 vs. the industry median of 18.43, Staar Surgical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.43, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Staar Surgical Co's current EV-to-EBIT of 174.65 is 847.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Staar Surgical Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Staar Surgical Co's current EV-to-EBIT is 174.65, which is 117% above median its own 10-year median of 80.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Modestly Undervalued. The stock's GF Value™ is $32.08, compared to a current price of $24.27 — trading 24.3% below its estimated fair value. The current EV-to-EBIT is 174.65, which is 117% above median its 10-year median of 80.45 and 847.6% above the Medical Devices & Instruments industry median of 18.43. Staar Surgical Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current EV-to-EBIT is 174.65 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $24.27 is trading 24.3% below its estimated GF Value™ of $32.08.
GuruFocus considers Staar Surgical Co to be Modestly Undervalued.
Key valuation signals for STAA:
EV-to-EBIT: 174.65 (117% above median its 10-year median of 80.45)
GF Value™: $32.08 vs. price of $24.27 (24.3% below fair value)
Industry Position: 847.6% above the Medical Devices & Instruments median (#451 of 465)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
83GF Score
Get the complete analysis for STAA
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 
